Double board-certified neurologist Dr. Russell Surasky on experimental Alzheimer’s drug

FAN Editor

OAN Alicia Summers
3:02 PM – Friday, May 5, 2023

There is a promising new experimental drug available for those with Alzheimer’s, made by Eli Lilly. The company reports that in a late-stage trial, it slowed the progression of the disease by 35%. The Alzheimer’s Association predicts that the number of Americans living with Alzheimer’s will increase from over 6 million now to almost 13 million by 2050. Double Board Certified Neurologist, Dr. Russell Surasky joins OAN’s Alicia Summers to provide further insights.


Free America Network Articles

Leave a Reply

Next Post

CEO of Sound Planning Group provides more context on the new jobs report and debt ceiling stalemate

OAN Alicia Summers3:09 PM – Friday, May 5, 2023 The monthly jobs report for April is better than expected. U.S. employers added 253,000 jobs last month, and the unemployment rate decreased from 3.5% to 3.4%. David Stryzewski, CEO of Sound Planning Group, is joining OAN’s Alicia Summers to provide more […]